Oscar A. Salomone
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Oscar A. Salomone has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Adela Sembaj
Universidad Nacional de Córdoba, Córdoba, Argentina
1 shared publicationAna L. Basquiera
Hospital Privado Centro Medico de Córdoba, Córdoba, Argentina
1 shared publicationAna M. Aguerri
Universidad Nacional de Córdoba, Córdoba, Argentina
1 shared publicationAtilio Palma
Universidad Nacional de Córdoba, Córdoba, Argentina
1 shared publicationJosé Moreno Barral
Universidad Nacional de Córdoba, Córdoba, Argentina
1 shared publicationJulio Enders
Universidad Nacional de Córdoba, Córdoba, Argentina
1 shared publication
Latest Publications
- Open Access
- 1 December 2003
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 9 (12) , 1558-1562
Trypanosoma cruzi in Persons without Serologic Evidence of Disease, Argentina
Current diagnosis of chronic Chagas disease relies on serologic detection of specific immunoglobulin G against Trypanosoma cruzi. However, the presence of parasites detected by polymerase chain reaction (PCR) in patients without positive conventional serologic testing has been observed. We determined the prevalence and clinical characteristics of persons with seronegative results for T. cruzi DNA detected by PCR in a population at high risk for chronic American trypanosomiasis. We studied a total of 194 persons from two different populations: 110 patients were recruited from an urban cardiology clinic, and 84 persons were nonselected citizens from a highly disease-endemic area. Eighty (41%) of persons had negative serologic findings; 12 (15%) had a positive PCR. Three patients with negative serologic findings and positive PCR results had clinical signs and symptoms that suggested Chagas cardiomyopathy. This finding challenges the current recommendations for Chagas disease diagnosis, therapy, and blood transfusion policies.
- 1 December 2003
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 9 (12) , 1558-1562
Open AccessTrypanosoma cruzi in Persons without Serologic Evidence of Disease, Argentina
Current diagnosis of chronic Chagas disease relies on serologic detection of specific immunoglobulin G against Trypanosoma cruzi. However, the presence of parasites detected by polymerase chain reaction (PCR) in patients without positive conventional serologic testing has been observed. We determined the prevalence and clinical characteristics of persons with seronegative results for T. cruzi DNA detected by PCR in a population at high risk for chronic American trypanosomiasis. We studied a total of 194 persons from two different populations: 110 patients were recruited from an urban cardiology clinic, and 84 persons were nonselected citizens from a highly disease-endemic area. Eighty (41%) of persons had negative serologic findings; 12 (15%) had a positive PCR. Three patients with negative serologic findings and positive PCR results had clinical signs and symptoms that suggested Chagas cardiomyopathy. This finding challenges the current recommendations for Chagas disease diagnosis, therapy, and blood transfusion policies.